Papillary cystadenocarcinoma

Common Name(s)

Papillary cystadenocarcinoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Papillary cystadenocarcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Papillary cystadenocarcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Papillary cystadenocarcinoma" returned 9 free, full-text research articles on human participants. First 3 results:

Urachal papillary cystadenocarcinoma: a rare case report.
 

Author(s): Kavita Mardi, Neelam Gupta

Journal: J Cancer Res Ther. ;7(2):223-5.

 

Urachal papillary mucinous cystadenocarcinoma is a rare tumor and represents 0.17-0.34% of all bladder tumors. It has an insidious course and variable clinical presentation. We present a case report of a 37-year-old female who presented with a lump in the abdomen. MRI revealed a solidcystic ...

Last Updated: 19 Jul 2011

Go To URL
A case of intratesticular endometrioid papillary cystadenocarcinoma.
 

Author(s): Kazuyuki Numakura, Norihiko Tsuchiya, Hiroshi Tsuruta, Takashi Obara, Mitsuru Saito, Takamitsu Inoue, Shintaro Narita, Yohei Horikawa, Shigeru Satoh, Hiroshi Nanjyo, Tomonori Habuchi

Journal: Jpn. J. Clin. Oncol.. 2011 May;41(5):674-6.

 

We report a case of intratesticular endometrioid papillary cystadenocarcinoma. A 73-year-old man was admitted for a painless right scrotal swelling. Ultrasonography and computed tomography revealed a large cystic mass in the right testis. Right scrotum puncture revealed xanthochromic ...

Last Updated: 3 May 2011

Go To URL
Papillary cystadenocarcinoma of submandibular salivary gland: a rare case report.
 

Author(s): Kavita Mardi, Sudarshan Sharma, Neelam Gupta

Journal: J Cancer Res Ther. ;6(3):330-2.

 

Papillary cystadenocarcinoma is an extremely rare malignant neoplasm characterized by cysts and papillary endophytic projections. It was first defined in 1991 by World Health organization as a separate entity. Major locations of this neoplasm are the parotid gland, the sublingual ...

Last Updated: 1 Dec 2010

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Papillary cystadenocarcinoma" returned 1 free, full-text review articles on human participants. First 3 results:

[A case of papillary cystadenocarcinoma of the prostate].
 

Author(s): A Yamasita, M Sakurai, T Kondo, K Arima

Journal: Nippon Hinyokika Gakkai Zasshi. 1997 Dec;88(12):1028-31.

 

An 86-year-old was admitted to our hospital with the complaint of urinary retension. Ultrasonography and CT scan revealed a large cystic intrapelvic mass which was palpated on the bilateral inguinal portion. When the needle aspiration was performed, we aspirated serous fluid which ...

Last Updated: 27 Feb 1998

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, Peritoneal Cancer, or Triple-Negative Breast Cancer
 

Status: Recruiting

Condition Summary: Estrogen Receptor-negative Breast Cancer; HER2-negative Breast Cancer; Ovarian Endometrioid Adenocarcinoma; Ovarian Papillary Serous Carcinoma; Ovarian Serous Cystadenocarcinoma; Progesterone Receptor-negative Breast Cancer; Recurrent Breast Cancer; Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer; Triple-negative Breast Cancer

 

Last Updated: 28 Jul 2014

Go to URL
MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
 

Status: Recruiting

Condition Summary: Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Recurrent Adult Brain Tumor; Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Epithelial Cancer; Stage IIIA Primary Peritoneal Cavity Cancer; Stage IIIB Fallopian Tube Cancer; Stage IIIB Ovarian Epithelial Cancer; Stage IIIB Primary Peritoneal Cavity Cancer; Stage IIIC Fallopian Tube Cancer; Stage IIIC Ovarian Epithelial Cancer; Stage IIIC Primary Peritoneal Cavity Cancer; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Primary Peritoneal Cavity Cancer; Unspecified Adult Solid Tumor, Protocol Specific

 

Last Updated: 28 Jul 2014

Go to URL
Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
 

Status: Not yet recruiting

Condition Summary: Brenner Tumor; Ovarian Carcinosarcoma; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Papillary Serous Carcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer

 

Last Updated: 30 Jun 2014

Go to URL